Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 9
Submit an article Journal homepage
284
Views
7
CrossRef citations to date
0
Altmetric
Letters to the Editor

Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia

Abhishek MaitiDepartment of Internal Medicine, The University of Texas Health Sciences Center at Houston, TX, USA; ;Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Jorge CortesDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Correspondence[email protected]
,
Alessandra FerrajoliDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Zeev EstrovDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Gautam BorthakurDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Guillermo Garcia-ManeroDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Elias JabbourDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Farhad RavandiDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
,
Susan O’BrienChao Family Comprehensive Cancer Center, University of California, Irvine, CA, USA
&
Hagop KantarjianDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;
show all
Pages 2240-2242 | Received 23 Sep 2016, Accepted 09 Jan 2017, Published online: 09 Feb 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Umut Yılmaz, Batuhan Bulan, Çağrı Belli & Ahmet Emre Eşkazan. (2022) Management of chronic myeloid leukemia in myeloid blastic phase with novel therapies: a systematic literature review. Expert Review of Hematology 15:5, pages 423-429.
Read now

Articles from other publishers (6)

Ammar Sarwar, Zeren Zhu, Man Zhu, Xiaoyu Tang, Qi Su, Tianfeng Yang, Wenjun Tang & Yanmin Zhang. (2023) Homoharringtonine sensitizes pancreatic cancer to erlotinib by direct targeting and miRNA-130b-3p-mediated EphB4-JAK2-STAT3 axis. Journal of Pharmacy and Pharmacology.
Crossref
Veerandra Kumar, Jyotirmayee & Malkhey Verma. (2022) Developing therapeutic approaches for chronic myeloid leukemia: a review. Molecular and Cellular Biochemistry 478:5, pages 1013-1029.
Crossref
Nihay Laham-Karam, Gaspar P. Pinto, Antti Poso & Piia Kokkonen. (2020) Transcription and Translation Inhibitors in Cancer Treatment. Frontiers in Chemistry 8.
Crossref
Peter E. Westerweel, Peter A. W. te Boekhorst, Mark-David Levin & Jan J. Cornelissen. (2019) New Approaches and Treatment Combinations for the Management of Chronic Myeloid Leukemia. Frontiers in Oncology 9.
Crossref
Bhavini B. Shah, Ruma Baksi, Kiranj K. Chaudagar, Manish Nivsarkar & Anita A. Mehta. (2018) Anti-leukemic and anti-angiogenic effects of d -Limonene on K562-implanted C57BL/6 mice and the chick chorioallantoic membrane model . Animal Models and Experimental Medicine 1:4, pages 328-333.
Crossref
Jian Chen, Qitian Mu, Xia Li, Xiufeng Yin, Mengxia Yu, Jing Jin, Chenying Li, Yile Zhou, Jiani Zhou, Shanshan Suo, Demin Lu & Jie Jin. (2017) Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells. Oncotarget 8:25, pages 40318-40326.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.